{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:14:27Z","timestamp":1761898467314,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.clinre.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T13:07:27Z","timestamp":1512652047000},"page":"255-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4580-585X","authenticated-orcid":false,"given":"Simon","family":"Pernot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Velut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rapahel Hampig","family":"Kourie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Amouyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Sapoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Laure","family":"Pointet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Landi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosra","family":"Zaimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Lep\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Pellerin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clinre.2017.11.004_bib0005","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clinre.2017.11.004_bib0010","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijrobp.2005.12.051","article-title":"Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience","volume":"65","author":"Kennedy","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clinre.2017.11.004_bib0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/SLA.0b013e3181b4539b","article-title":"Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669\u00a0patients","volume":"250","author":"De Jong","year":"2009","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.clinre.2017.11.004_bib0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1245\/s10434-013-3297-7","article-title":"Cause of death from liver metastases in colorectal cancer","volume":"21","author":"Helling","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clinre.2017.11.004_bib0025","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.3747\/co.21.1592","article-title":"Hepatic arterial infusion pump chemotherapy for colorectal liver metastases: an old technology in a new era","volume":"21","author":"Ko","year":"2014","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.clinre.2017.11.004_bib0030","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.3747\/co.21.1577","article-title":"Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement","volume":"21","author":"Karanicolas","year":"2014","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clinre.2017.11.004_bib0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2407-7-69","article-title":"Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: a phase II-study and historical comparison with the surgical approach","volume":"7","author":"Hildebrandt","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clinre.2017.11.004_bib0040","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinre.2017.11.004_bib0045","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/SLA.0b013e3181d35983","article-title":"Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases","volume":"251","author":"Go\u00e9r\u00e9","year":"2010","journal-title":"Ann Surg"},{"issue":"22","key":"10.1016\/j.clinre.2017.11.004_bib0050","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1200\/JCO.2005.05.120","article-title":"Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the F\u00e9d\u00e9ration Nationale des Centres de Lutte Contre le Cancer","volume":"23","author":"Ducreux","year":"2005","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.clinre.2017.11.004_bib0055","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1200\/JCO.2008.20.1301","article-title":"Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma","volume":"27","author":"Kemeny","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clinre.2017.11.004_bib0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1245\/s10434-007-9581-7","article-title":"Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure","volume":"15","author":"Boige","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.clinre.2017.11.004_bib0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/1097-0142(19860201)57:3<492::AID-CNCR2820570315>3.0.CO;2-M","article-title":"Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries","volume":"57","author":"Kemeny","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.clinre.2017.11.004_bib0070","doi-asserted-by":"crossref","unstructured":"Lorenz M, M\u00fcller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 18(2) 2000:243\u201354.","DOI":"10.1200\/JCO.2000.18.2.243"},{"issue":"6","key":"10.1016\/j.clinre.2017.11.004_bib0075","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/annonc\/mdg247","article-title":"Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer","volume":"14","author":"Fallik","year":"2003","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.clinre.2017.11.004_bib0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/annonc\/mdh022","article-title":"Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver","volume":"15","author":"van Riel","year":"2004","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.clinre.2017.11.004_bib0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/(SICI)1096-9098(199706)65:2<127::AID-JSO10>3.0.CO;2-2","article-title":"Superselective intra-arterial chemotherapy with mitomycin C in hepatic metastases from colorectal cancer","volume":"65","author":"M\u00e4kel\u00e4","year":"1997","journal-title":"J Surg Oncol"},{"issue":"6","key":"10.1016\/j.clinre.2017.11.004_bib0090","first-page":"1085","article-title":"Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study","volume":"21","author":"Fiorentini","year":"2007","journal-title":"In Vivo"},{"issue":"23","key":"10.1016\/j.clinre.2017.11.004_bib0095","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1200\/JCO.2010.28.5643","article-title":"Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy","volume":"28","author":"Hendlisz","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clinre.2017.11.004_bib0100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jvir.2013.11.027","article-title":"Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations","volume":"25","author":"Lencioni","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.clinre.2017.11.004_bib0105","first-page":"CD007823","article-title":"Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer","volume":"3","author":"Mocellin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.clinre.2017.11.004_bib0110","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.1992.10.7.1112","article-title":"Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial","volume":"10","author":"Rougier","year":"1992","journal-title":"J Clin Oncol"},{"issue":"8932","key":"10.1016\/j.clinre.2017.11.004_bib0115","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(94)90750-1","article-title":"Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases","volume":"344","author":"Allen-Mersh","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2017.11.004_bib0120","first-page":"198","article-title":"Phase II study of intra-arterial fluorouracil and mitomycin-C for liver metastases of colorectal cancer. Recent results","volume":"121","author":"Metzger","year":"1991","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.clinre.2017.11.004_bib0125","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00330-007-0781-0","article-title":"Palliative hepatic intraarterial chemotherapy (HIC) using a novel combination of gemcitabine and mitomycin C: results in hepatic metastases","volume":"18","author":"Vogl","year":"2008","journal-title":"Eur Radiol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740117302607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740117302607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:26:33Z","timestamp":1761895593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740117302607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S2210740117302607"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2017.11.004","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}